Application of Autophagy in Cardiovascular Diseases

Jie Du1, Yulin Li2, Congcong Zhang2

  • 1Beijing Anzhen Hospital Affiliated with Capital Medical University, Beijing, China. jiedubj@126.com.

Insights

Autophagy, a cellular process, is linked to cardiovascular disease development. Modulating autophagy with activators or inhibitors shows promise as a novel therapeutic strategy for heart conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Medicine

Background:

  • Autophagy plays a critical role in cellular homeostasis and stress response.
  • Dysregulation of autophagy is implicated in the pathogenesis and progression of various cardiovascular diseases, including heart failure and atherosclerosis.
  • Understanding the intricate mechanisms of autophagy is crucial for developing effective cardiovascular therapies.

Purpose of the Study:

  • To review the current literature on the role of autophagy in cardiovascular diseases.
  • To summarize the potential of autophagy modulators (activators and inhibitors) as therapeutic agents for cardiovascular conditions.
  • To provide an overview of key autophagy pathways relevant to cardiovascular health and disease.

Main Methods:

  • Literature review of preclinical and clinical studies on autophagy and cardiovascular diseases.
  • Analysis of experimental data on the effects of autophagy activators and inhibitors in cardiovascular models.
  • Synthesis of information regarding the molecular targets and mechanisms of autophagy modulation in the context of heart disease.

Main Results:

  • Autophagy is a double-edged sword in cardiovascular disease, with context-dependent roles.
  • Pharmacological activation or inhibition of autophagy can exert protective or detrimental effects on the cardiovascular system.
  • Specific autophagy pathways are associated with distinct cardiovascular pathologies, offering targeted therapeutic opportunities.

Conclusions:

  • Autophagy represents a promising, yet complex, therapeutic target for cardiovascular diseases.
  • Further research is needed to elucidate the precise roles of different autophagy pathways in specific cardiovascular conditions.
  • Development of selective autophagy modulators holds potential for novel cardiovascular drug discovery.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
201
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K